1. Home
  2. QTRX vs CAF Comparison

QTRX vs CAF Comparison

Compare QTRX & CAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTRX
  • CAF
  • Stock Information
  • Founded
  • QTRX 2007
  • CAF 2006
  • Country
  • QTRX United States
  • CAF United States
  • Employees
  • QTRX N/A
  • CAF N/A
  • Industry
  • QTRX Biotechnology: Laboratory Analytical Instruments
  • CAF Investment Managers
  • Sector
  • QTRX Industrials
  • CAF Finance
  • Exchange
  • QTRX Nasdaq
  • CAF Nasdaq
  • Market Cap
  • QTRX 241.2M
  • CAF 276.0M
  • IPO Year
  • QTRX 2017
  • CAF N/A
  • Fundamental
  • Price
  • QTRX $5.71
  • CAF $16.49
  • Analyst Decision
  • QTRX Hold
  • CAF
  • Analyst Count
  • QTRX 4
  • CAF 0
  • Target Price
  • QTRX $11.75
  • CAF N/A
  • AVG Volume (30 Days)
  • QTRX 595.8K
  • CAF 63.6K
  • Earning Date
  • QTRX 11-10-2025
  • CAF 01-01-0001
  • Dividend Yield
  • QTRX N/A
  • CAF 1.02%
  • EPS Growth
  • QTRX N/A
  • CAF N/A
  • EPS
  • QTRX N/A
  • CAF N/A
  • Revenue
  • QTRX $130,203,000.00
  • CAF N/A
  • Revenue This Year
  • QTRX N/A
  • CAF N/A
  • Revenue Next Year
  • QTRX $37.03
  • CAF N/A
  • P/E Ratio
  • QTRX N/A
  • CAF N/A
  • Revenue Growth
  • QTRX N/A
  • CAF N/A
  • 52 Week Low
  • QTRX $4.05
  • CAF $11.63
  • 52 Week High
  • QTRX $13.01
  • CAF $14.38
  • Technical
  • Relative Strength Index (RSI)
  • QTRX 58.21
  • CAF 47.80
  • Support Level
  • QTRX $4.50
  • CAF $16.38
  • Resistance Level
  • QTRX $5.46
  • CAF $17.09
  • Average True Range (ATR)
  • QTRX 0.34
  • CAF 0.32
  • MACD
  • QTRX 0.02
  • CAF -0.07
  • Stochastic Oscillator
  • QTRX 96.89
  • CAF 7.12

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

About CAF Morgan Stanley China A Share Fund Inc.

Morgan Stanley China A Share Fund Inc is the United States based non-diversified, closed-end management investment company. Its investment objective is to seek capital growth by investing a majority of its assets in A-shares of Chinese companies listed on the Shanghai and Shenzhen Stock Exchanges. Its portfolio of investments consists of investment in different sectors such as the aerospace and defense, banks, automobiles, household durables, media, pharmaceuticals, software and other sectors.

Share on Social Networks: